Stevioside, a constituent of Stevia rebaudiana, is commonly used as a noncaloric sugar substitute in Japan. Consistent with reports in the literature, we have found that stevioside is not mutagenic as judged by utilization of Salmonella typhimurium strain TM677, either in the presence or in the absence of a metabolic activating system. Similar negative results were obtained with several structurally related sweet-tasting glycosides. However, steviol, the aglycone of stevioside, was found to be highly mutagenic when evaluated in the presence of a 9000 X g supernatant fraction derived from the livers of Aroclor 1254-pretreated rats. Expression of mutagenic activity was dependent on both pretreatment of the rats with Aroclor 1254 and addition of NADPH; unmetabolized steviol was not active. The structurally related species, isosteviol, was not active regardless of metabolic activation. Similarly, chemical reduction of the unsaturated bond linking the carbon-16 and -17 positions of steviol resulted in the generation of two isomeric products, dihydrosteviol A and B, that were not mutagenic. In addition, ent-kaurenoic acid was found to be inactive. It is therefore clear that a metabolite of an integral component of stevioside is mutagenic; structural features of requisite importance for the expression of mutagenic activity include a hydroxy group at position 13 and an unsaturated bond joining the carbon atoms at positions 16 and 17. A potential metabolite of steviol, steviol-16a,17-epoxide, was synthesized chemically and found to be ineffective, as. a direct-acting mutagen. Thus, although stevioside itself 'appears innocuous, it would seem prudent to expeditiously and unequivocally establish the human metabolic disposition of this substance.
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Stevia rebaudiana Bertoni (Compositae) is a sweet herb indigenous to elevated terrain in the northeastern corner of Paraguay, adjacent to its frontier with Brazil (1) . Extracts of this plant and stevioside, its major sweet constituent, are commercially available in Japan, where they have been used for nearly a decade to sweeten a variety of foods including sea foods, pickled vegetables, dessert items, soft drinks, and confectionery (2) (3) (4) . Recently, S. rebaudiana products were cleared for sale in Brazil (5, 6) , and they are also used in Paraguay for the treatment of hyperglycemia (1) .
Stevioside is one of eight known sweet ent-kaurene glycoside constituents of S. rebaudiana, with the others being steviolbioside, rebaudiosides A-E, and dulcoside A (7) . The results of several studies to assess the safety for human consumption of certain of these compounds and S. rebaudiana extracts have appeared in the literature. For example, neither stevioside nor two different S. rebaudiana extracts were found to be significantly active during acute toxicity tests in mice and subacute toxicity tests in rats (8) . Also, no dose-related abnormalities in an extensive range of blood chemistry values were observed after subacute oral administration to rats of a S. rebaudiana extract containing 50% (wt/wt) stevioside, apart from a significant decrease in lactic acid dehydrogenase levels (9) . Stevioside and crude extracts derived from S. rebaudiana have been determined to be donmutagenic in several laboratories when tested against several strains of Salmonella typhimurium, Escherichia coli, and Bacillus subtilis, both in the presence and in the absence of a metabolic activating system derived from the liver of rats (2, 10, 11). In addition, no activity was demonstrated by these same test materials in a silkworm oocyte test system, and they did not enhance sister chromatid exchange with human fetal fibroblasts or induce chromosomal aberrations with these cells or rat medullary cells (11) .
The present paper describes mutagenicity studies carried out with steviol (ent-13-hydroxykaur-16-en-19-oic acid) and several of its sweet glycosides and other derivatives. We report here that steviol is mutagenic toward S. typhimurium strain TM677, in the presence of a 9000 x g supernatant fraction obtained from the liver of Aroclor 1254-pretreated rats. The potential importance of the results in relation to the human ingestion of stevioside is discussed.*
MATERIALS AND METHODS
Isolation of Stevioside and Structurally Related Sweet Diterpene Glycosides. The steviol (1) glycosidest stevioside (3) , rebaudioside A (5), rebaudioside C (6), and dulcoside A (7) were isolated from a 1-butanol-soluble extract of S. rebaudiana by absorption chromatography as described by Kinghorn et al. (13) . Steviolbioside (2) and rebaudioside B (5) were prepared from stevioside and rebaudioside A, respectively, by alkaline hydrolysis (13) .
Preparation of Steviol from Stevioside. Stevioside (11 g) was treated with sodium periodate and sodium hydroxide as described by Ogawa et al. (14) . The residue obtained after workup of the reaction mixture was chromatographed over a 5.5 x 100 cm column containing silica gel (particle size, 63- ,B-Glc-13-Glc(2 -* 1) (16) . The pure aglycone (3.1 g) obtained after workup exhibited physical and spectroscopic data identical to those of steviol produced from stevioside by the procedure described above.
Preparation of Isosteviol from Stevioside. Isosteviol (8) was prepared from stevioside (25 g ) by reaction with 20% aqueous H2SO4 (750 ml) on a steam bath for 5 hr.
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The reaction mixture was cooled and extracted with chloroform (5 x 300 ml), and the pooled chloroform layers were washed with water and allowed to evaporate under reduced pressure to yield a residue. This residue was chromatographed over 200 g silica gel, eluting with chloroform (2 liters). Removal of solvent and crystallization from methanol gave pure isosteviol (4.5 g), which exhibited physical and spectroscopic data closely comparable with previously published values (17) .
Preparation of Dihydrosteviol A and Dihydrosteviol B by Hydrogenation of Steviol. Steviol (1 g) was dissolved in ethanol (75 ml) and hydrogenated by passing hydrogen gas in the presence of 5% platinum on activated carbon catalyst (Aldrich) through the solution overnight at room temperature. On workup, the solid residue was purified by column chromatography over silica gel. Elution with petroleum ether/acetone, 23 Spectral data measured for 11 were consistent with the proposed structure of this compound; its stereochemistry was assigned on the basis of expected attack by the epoxidizing agent on the less hindered side of the steviol molecule (19, 20) . When 11 was methylated with diazomethane, the product exhibited physical and spectroscopic data identical to those of the known compound steviol-16a,17-epoxide methyl ester (21) .
Treatment of Animals and Isolation of the 9000 x g Liver
Supernatant. Male Sprague-Dawley rats (body weight, 100-120 g, King Animal Laboratories, Oregon, WI) were housed in air-conditioned quarters with a 12-hr/12-hr light-dark cycle and given food and water ad lib. The rats (generally groups of 10) were given (i) no treatment, (ii) a single i.p. injection of Aroclor 1254 (400 mg/kg of body weight in corn oil), (iii) four consecutive daily i.p. injections of 3-methylcholanthrene (25 mg/kg of body weight in corn oil), or (iv) four consecutive daily i.p. injections of phenobarbital (75 mg/kg of body weight in H20).
Either 4 days after treatment with Aroclor 1254 or the day after the final treatment with 3-methylcholanthrene or phenobarbital, the rats were sacrificed by decapitation. The liver was immediately excised, rinsed several times with cold 0.14 M NaCl, minced, and homogenized with 3 vol (vol/wt) of 50 mM Tris HCl, pH 7.5/0.14 M KCl using a glass homogenizing vessel and a motor-driven Teflon pestle. The homogenate was filtered through cheesecloth and centrifuged at 800 x g for 10 min. The resulting supernatant was then centrifuged at 9000 x g for 20 min to yield the S-9 fraction. Protein was estimated by the method of Lowry et al. (22) using bovine serum albumin as the standard, and the isolate was stored as small aliquots in liquid nitrogen. All of the isolation procedures described above were conducted at 0-40C. 
RESULTS
As shown in Table 1 , no significant mutagenic activity was found when ent-kaurene glycosides 2-7 were assayed in the presence of the S-9 fraction derived from Aroclor 1254-pretreated rats. Mutagenic activity was also not significant when the bacteria were treated with the test substances in the absence of the S-9 fraction (data not shown) and, under either of the test conditions, no bactericidal activity has been noted. Similar negative results have been reported on assessing stevioside for mutagenic activity with other Salmonella strains (2, 10, 11) .
At the highest concentration tested, however, steviol (1) was found to have substantial mutagenic activity (Table 1) . To verify and further characterize the mutagenic potential of this substance, the bacteria were treated with it at various concentrations. The data summarized in Table 2 10 mg/ml in the absence of the S-9 fraction, however, no significant activity was detected (data not shown). Steviol was added to the reaction mixtures at the indicated concentration. Other conditions were as described for Table 1 .
The steviol used for the studies described above was obtained by treatment of stevioside with sodium periodate and potassium hydroxide followed by chromatographic purification. Although unlikely, it was of concern that a small quantity of a chemical contaminant might have copurified with the steviol and elicited the mutagenic/bactericidal response. Thus, to negate this possibility, steviol was also prepared by an enzymatic procedure (16) . Comparison of results obtained with steviol derived from nonmutagenic stevioside by either of these procedures showed no significant differences in activity.
Studies were then carried out to examine the metabolic conditions required to facilitate the mutagenic potential of steviol. As shown in Table 3 , slight activity was observed when steviol was incubated with NADPH or the Aroclor 1254 S-9 fraction in the presence of bacteria, but the greatest mutagenic and bactericidal response required admixture of these substances. Further, under the reaction conditions used, the S-9 fraction derived from control or 3-methylcholanthrene-pretreated rats was unable to effectively catalyze steviol-mediated mutagenesis whereas the preparation obtained from phenobarbital pretreated rats was effective in this process. Thus, the required pretreatment (with Aroclor 1254 or phenobarbital) and addition of NADPH strongly suggests a cytochrome P-450-mediated metabolic activation of steviol to a mutagenic species.
The mixed-function oxidase system, of course, is known to catalyze a variety of metabolic conversions (26, 27 Each incubation mixture contained steviol at 2.5 mg/ml; NADP+ and a NADPH-regenerating system were present or absent as indicated. The average mutant fraction obtained on addition of solvent only was 11.6 x 10-. S-9 fractions obtained from pretreated rats contained protein as follows: Aroclor 1254, 2.9 mg; control, 1.6 mg; phenobarbital, 2.7 mg; 3-methylcholanthrene, 2.5 mg.
Proc. NatL Acad ScL USA 82 (1985) Proc. NatL Acad. Sci. USA 82 (1985) 2481 [8] [9] [10] were tested in the presence of the S-9 fraction derived from Aroclor 1254-pretreated rats and a NADPH-regenerating system, whereas 11 was assayed directly. No significant bactericidal activity was found. ND, not determined.
of the S-9 fraction (data not shown). Moreover, the results obtained with the two isomeric species obtained on catalytic reduction of the double bond (9 and 10) strongly support the requirement of this functional group since neither of these compounds was mutagenic in the presence of a metabolic activating system (Table 4) . Similarly, no activity was detected with 9 or 10 in the absence of a metabolic activating system (data not shown).
Thus, analogous to compounds such as aflatoxin B1 and benzo[a]pyrene, steviol requires both metabolic activation and the presence of a double bond to function as a mutagen. A unique structural feature of steviol, however, is an adjacent hydroxyl group located at position 13. The importance of this functional group was investigated by evaluating the mutagenic potential of ent-kaurenoic acid (12) . When tested at concentrations as high as 5 mg/ml, this substance had neither toxic nor mutagenic activity in the presence or absence of a metabolic activating system (data not shown).
Finally, since several carcinogens are well-known to function as active mutagens subsequent to the metabolic generation of an epoxide or arene oxide (29) (30) (31) (32) , an epoxide of steviol (11) was synthesized chemically and tested directly for mutagenic activity. In the absence of a metabolic activating system, 11 did not serve as a mutagen (Table 4) . It also was not bactericidal. In addition, no significant activity was found in the presence of a metabolic activating system derived from rat liver (data not shown).t DISCUSSION Stevioside and the crude product used as a sweetening agent that is prepared from S. rebaudiana have been subjected to many standard genetic toxicological evaluations (2, 10, 11) . Consistent with the results reported in the present study, no mutagenic activity has been found with stevioside on treatment of a variety of bacterial strains (2, 10, 11) . Also reported here is the fact that an additional group of sweet-tasting glycosides structurally related to stevioside (4) (5) (6) (7) are not mutagenic. Thus, the lack of mutagenic or genotoxic activity observed in these assays attests to the safety of stevioside.
Importantly, however, the aglycone of stevioside, steviol, is highly mutagenic. Metabolic activation is required to potentiate this activity. Under the assay conditions used for the metabolic activation and assessment of steviol, the mutagenic response at a concentration of 2.5 mg/ml was similar to tWe have thus far been unable to efficiently synthesize and evaluate the isomeric counterpart of 11 as a direct acting mutagen. Although the species tested does not appear analogous to a mutagenic metabolite of steviol, the lack of activity in the presence of the rat liver S-9 fraction provides additional support for the functional importance of the carbon-16/carbon-17 region of the molecule.
that obtained with 80 ,M benzo[a]pyrene or 150 uM 2-acetylaminofluorene (data not shown). For activity of this magnitude, it is likely that covalent interaction with bacterial DNA occurs (33, 34) .
In further characterizing steviol-mediated mutagenicity, the following has been established: (i) Both NADPH and the rat liver S-9 fraction are required for activity, (ii) pretreatment of the rats with an inducer of cytochrome P-450 (Aroclor 1254 or phenobarbital) is necessary, (iii) structural congeners of steviol in which the carbon-16/carbon-17 double bond is sterically hindered (2) (3) (4) (5) (6) (7) or reduced (9 and 10) are not active as mutagens, (iv) an analog of steviol (12) On the basis of these data, it is probable that steviol is metabolized to active mutagenic species by the cytochrome P-450 system. However, since the synthetic steviol epoxide did not generate a mutagenic response, and rat liver fractions have been shown to produce several steviol metabolites, § the chemical structure of the mutagenic species remains to be elucidated. Because of a variety of factors, the commercial availability of a noncariogenic and/or noncaloric sugar substitute is highly desirable. Stevioside, which is 300-fold sweeter than sucrose (35) , is currently used as such an agent in Japan and Brazil. For example, it was estimated in 1979 that 700-1000 tons of S. rebaudiana leaves were cultivated or imported for use in Japan (2), and one company is reported to be producing 2-3 tons of stevioside per month (35) . The resulting material is either used directly or added to a variety of foods (2) (3) (4) and, therefore, it must be assumed that several tons of stevioside are ingested by the Japanese population on an annual basis. Similarly, S. rebaudiana tea and capsules were officially approved to be offered for sale in Brazil in 1980 (5, 6) .
In Paraguay, reports have indicated that S. rebaudiana was used to sweeten various beverages even before colonization by the Spaniards in the 16th century (36) . Modem use, however, relates primarily to reports in the literature that have indicated a hypoglycemic effect of the substance (1). For example, one product sold for this purpose recommends an initial dose of S. rebaudiana leaves of up to 5 g/day for patients with high blood sugar, followed by a maintenance dose of 1 g/day.
It is therefore clear that human consumption of stevioside is fairly widespread. In the context of results presented in this communication, the questions of imminent importance are the chemical stability and metabolic disposition of this substance. Considering the former, a variety of chemical reaction conditions have been shown to result in the production of isosteviol (18, 28) . Refluxing stevioside for 5 hr in aqueous methanol/1.5% HCl gives isosteviol in 78% yield (28) . In a comprehensive study in which stevioside was incubated for up to 3 months at pH values ranging from 2 to 8 and §In separate experiments using incubation conditions known to mediate bacterial mutagenesis, the enzymic generation of approximately 10 
